{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:52:30Z","timestamp":1791647550530,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.prro.2026.10.001","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:26:55Z","timestamp":1791646015000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Re-irradiation for recurrent high-grade glioma: current evidence and practical considerations"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-1161","authenticated-orcid":false,"given":"Emerson","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Tanguturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prro.2026.10.001_bib0001","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s11060-025-05195-7","article-title":"Pattern of recurrence with 1.0 cm CTV in brain glioblastoma treated with radiotherapy","volume":"175","author":"Braschi","year":"2025","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.prro.2026.10.001_bib0002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13014-021-01767-9","article-title":"Current status and recent advances in reirradiation of glioblastoma","volume":"16","author":"Minniti","year":"2021","journal-title":"Radiat Oncol"},{"issue":"34","key":"10.1016\/j.prro.2026.10.001_bib0003","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.1200\/JCO.2005.03.4157","article-title":"Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution","volume":"23","author":"Combs","year":"2005","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.prro.2026.10.001_bib0004","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ijrobp.2009.11.058","article-title":"Reirradiation of Large-Volume Recurrent Glioma With Pulsed Reduced-Dose-Rate Radiotherapy","volume":"79","author":"Adkison","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.prro.2026.10.001_bib0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijrobp.2008.10.043","article-title":"Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas","volume":"75","author":"Gutin","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.prro.2026.10.001_bib0006","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11060-020-03526-4","article-title":"Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma","volume":"148","author":"Bergman","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.prro.2026.10.001_bib0007","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2019.06.009","article-title":"Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma","volume":"138","author":"Fleischmann","year":"2019","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"6","key":"10.1016\/j.prro.2026.10.001_bib0008","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/neuonc\/not216","article-title":"Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma","volume":"16","author":"Schmainda","year":"2014","journal-title":"Neuro-Oncol"},{"issue":"5","key":"10.1016\/j.prro.2026.10.001_bib0009","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.adro.2020.03.022","article-title":"Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry","volume":"5","author":"Saeed","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.prro.2026.10.001_bib0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/1078-0432.CCR-24-1629","article-title":"Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma","volume":"31","author":"Iwamoto","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prro.2026.10.001_bib0011","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2147\/OTT.S60358","article-title":"Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study","volume":"7","author":"Greenspoon","year":"2014","journal-title":"OncoTargets Ther"},{"issue":"18","key":"10.1016\/j.prro.2026.10.001_bib0012","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2009.25.6941","article-title":"Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas","volume":"28","author":"Fogh","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.prro.2026.10.001_bib0013","series-title":"A Dual Phase 1\/2, Investigator Initiated Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of 186Rhenium Nanoliposomes (186RNL) in Recurrent Glioma (CTRC# 12-02)","year":"2025"},{"key":"10.1016\/j.prro.2026.10.001_bib0014","series-title":"Pilot Study of Laser Interstitial Thermal Therapy Followed By Hypofractionated Radiation Therapy for Treatment of Recurrent Gliomas","year":"2026"},{"key":"10.1016\/j.prro.2026.10.001_bib0015","series-title":"Contribution From PET-DOPA in Glioblastoma Re-Irradiation - A Randomized Phase II Study","year":"2026"},{"key":"10.1016\/j.prro.2026.10.001_bib0016","series-title":"Lomustine With and Without Reirradiation for First Progression of Glioblastoma: A Randomized Phase III Study. clinicaltrials.gov","year":"2026"},{"key":"10.1016\/j.prro.2026.10.001_bib0017","series-title":"PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies (POPCORN) Trial","year":"2025"},{"issue":"0","key":"10.1016\/j.prro.2026.10.001_bib0018","article-title":"Constraints, cumulative doses and toxicity outcomes in glioma reirradiation: a systematic review and radiobiological comparison from the Reirradiation Collaborative Group (ReCog)","volume":"0","author":"Slevin","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.prro.2026.10.001_bib0019","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ijrobp.2025.03.002","article-title":"Reirradiation Special Medical Physics Consultations: Lessons Learned From Nearly 3000 Courses of Treatment","volume":"122","author":"Paradis","year":"2025","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2026.10.001_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1748-717X-8-287","article-title":"Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma","volume":"8","author":"Niyazi","year":"2013","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.prro.2026.10.001_bib0021","first-page":"132","article-title":"High-dose re-irradiation of intracranial lesions - Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation","volume":"27","author":"Stiefel","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"10.1016\/j.prro.2026.10.001_bib0022","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.prro.2022.12.006","article-title":"A Prospective Study of Conventionally Fractionated Dose Constraints for Reirradiation of Primary Brain Tumors in Adults","volume":"13","author":"McGovern","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2026.10.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2026.06.3058","article-title":"Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single-Institution Series","author":"Linkowski","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026003206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026003206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:27:00Z","timestamp":1791646020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850026003206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"alternative-id":["S1879850026003206"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2026.10.001","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-irradiation for recurrent high-grade glioma: current evidence and practical considerations","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2026.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}